TY  - GEN
AU  - Even,C
AU  - Lassen,U
AU  - Merchan,J
AU  - Le Tourneau,C
AU  - Soria,J-C
AU  - Ferte,C
AU  - Ricci,F
AU  - Diener,J T
AU  - Yuen,E
AU  - Smith,C
AU  - Oakley,G J
AU  - Benhadji,K A
AU  - Massard,Christophe
TI  - Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma
SN  - 1573-0646
PY  - 2021///0303
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Benzazepines
KW  - Carcinoma, Adenoid Cystic
KW  - drug therapy
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Progression-Free Survival
KW  - Receptor, Notch1
KW  - antagonists & inhibitors
KW  - Tumor Burden
KW  - drug effects
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s10637-019-00739-x
ER  -